NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 48 filers reported holding NUVALENT INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,101,416 | +223.6% | 197,986 | +196.9% | 0.00% | +200.0% |
| Q2 2023 | $2,812,317 | +88.7% | 66,690 | +16.8% | 0.00% | – |
| Q1 2023 | $1,490,130 | -11.5% | 57,115 | +1.0% | 0.00% | -100.0% |
| Q4 2022 | $1,684,655 | +90.4% | 56,570 | +24.3% | 0.00% | – |
| Q3 2022 | $885,000 | +60.0% | 45,497 | +11.7% | 0.00% | – |
| Q2 2022 | $553,000 | -10.5% | 40,721 | -8.3% | 0.00% | – |
| Q1 2022 | $618,000 | +19.3% | 44,429 | +63.5% | 0.00% | – |
| Q4 2021 | $518,000 | -11.8% | 27,172 | +4.4% | 0.00% | – |
| Q3 2021 | $587,000 | – | 26,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
| Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
| Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
| COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
| Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
| Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
| Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
| Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
| Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |